#40 of India's imports · #2 of pharma imports · Antibiotics
Erythromycin & derivatives: imports into India
Tariff line 29415000 · CAS 114-07-8
Imports 2025-26
2,037 t
+13.6% vs 2024-25
Import bill (CIF, before duty)
₹1,676 cr
Volume growth, 2020-21 to 2025-26
0% a year
Steady
Net imports 2025-26
1,283 t
Exports 754 t
Import volume by financial year
SteadyShow as table
| Year | Imports | Import bill |
|---|---|---|
| 2020-21 | 2,042 t | ₹1,141 cr |
| 2021-22 | 1,756 t | ₹1,120 cr |
| 2022-23 | 1,440 t | ₹941 cr |
| 2023-24 | 1,868 t | ₹1,368 cr |
| 2024-25 | 1,793 t | ₹1,441 cr |
| 2025-26 | 2,037 t | ₹1,676 cr |
Where it comes from (2025-26)
Share of the import bill
- China98.8%
- Spain<1%
- Thailand<1%
What's changing
- Erythromycin was among 11 products for which the government re-opened applications under the bulk-drug PLI scheme in May 2025, with incentives for fermentation-based products running to 2028-29.Eastern Mirror (PTI), 25 May 2025
Reported facts with their source. Not a forecast.
Buy or supply erythromycin & derivatives in India
Source: Export Import Data Bank, Department of Commerce (DGCI&S data), as published on 10 Nov 2026. The import bill is the total declared value, not a price per kg. How to read these figures.